Authors: Madison Muller August 25, 2022 Bloomberg Almost 40% of people hospitalized in the US with the Covid subvariant that circulated this spring were vaccinated and boosted, highlighting how new strains have mutated to more readily escape the immunity offered by current shots. The findings from scientists at the US Centers for Disease Control and […]
Authors: Mark Terry Published: Mar 01, 2022 BIOSPACE Pfizer-BioNTech Vaccine Only 12% Effective Against Omicron in 5-11-Year-Olds In a new study that is yet to be peer-reviewed, the New York State Department of Health found that the Pfizer–BioNTech vaccine was only about 12% effective for children ages 5 to 11 years against the Omicron variant. In that age group, it […]
— It’s pretty simple — they can’t Authors: by Veronica Hackethal, MD, MSc, Enterprise & Investigative Writer, MedPage Today March 12, 2021 Adenoviral vector vaccines have been in development for decades, but very few have been approved for use in humans. What does the history of adenoviral vector vaccine development tell us about their safety and their […]
Authors: By Serena Marshall and Lara Salahi February 24, 2021 — The newest COVID shot uses an existing technology but one with lingering questions As the U.S. hits the half-million death mark from COVID-19 — a grim milestone that is equal to roughly the entire population of Atlanta and more than that of Miami — a new […]
